← FDA Drug Approvals (Drugs@FDA)

KETAMINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2023-01-13

Drug application

FDA Application #

ANDA215808

Application type

Abbreviated New Drug Application (Generic)

Brand name

KETAMINE HYDROCHLORIDE

Generic name

KETAMINE HYDROCHLORIDE

Active ingredients

KETAMINE HYDROCHLORIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

FRESENIUS KABI USA

Manufacturer

Fresenius Kabi USA, LLC

First approval

2023-01-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown